Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Designation crawled time : 11:00 save search
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
CABA | $13.96 -7.86% -8.52% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.44%
C: 0.67%
caba-201 fda drug granted sclerosis treatment designation
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
PCRX | $26.12 -2.43% -2.49% 620K
|
Health Technology
|
| O: 0.03%
H: 1.24%
C: -0.92%
pcrx-201 osteoarthritis granted treatment designation therapy
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
Published: 2024-03-12 (Crawled : 11:00) - biospace.com/
KALV | $11.53 -1.03% -1.04% 410K
|
Health Technology
|
| O: -1.83%
H: 1.63%
C: -2.88%
sebetralstat pharmaceuticals designation
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases
Published: 2023-11-03 (Crawled : 11:00) - globenewswire.com
PSTV | $1.765 -0.57% 6.7K
|
Health Technology
|
| O: 9.56%
H: 12.08%
C: 7.38%
fda drug breast granted cancer treatment designation therapeutics plus
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
IMTX | $10.26 0.29% 0.29% 440K
|
Health Technology
|
| O: -0.13%
H: 4.18%
C: 1.77%
ima203 actengine fda designation therapy
Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
ANNX | $4.435 -3.27% -3.38% 1.4M
|
Health Technology
|
| O: 3.57%
H: 10.92%
C: 4.6%
anx007 treatment designation prime ema
Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
Published: 2023-09-28 (Crawled : 11:00) - globenewswire.com
BOLT | $1.15 3.6% 3.48% 89K
|
|
| O: 9.9%
H: 2.7%
C: -6.31%
bdc-1001 drug treatment designation
Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP
Published: 2023-09-26 (Crawled : 11:00) - globenewswire.com
VIGL | $2.75 -5.82% -6.18% 50K
|
|
| O: -2.5%
H: 13.7%
C: 3.94%
vgl101 drug positive treatment designation
Kymera Therapeutics Receives U.S. FDA Fast Track Designation for KT-333, a First-in-Class, Investigational STAT3 Degrader for the Treatment of Relapsed/Refractory Cutaneous T-Cell Lymphoma and Relapsed/Refractory Peripheral T-Cell Lymphoma
Published: 2023-09-18 (Crawled : 11:00) - globenewswire.com
KYMR | $35.16 4.15% 3.98% 620K
|
Health Technology
|
| O: 1.0%
H: 1.92%
C: -0.78%
kt-333 fda t-cell treatment designation therapeutics
Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
Published: 2023-09-12 (Crawled : 11:00) - globenewswire.com
AFMD | $5.1 -2.49% -2.55% 90K
|
Health Technology
|
| O: 4.1%
H: 4.71%
C: -1.73%
afm13 allonk fda treatment designation fast track designation
Krystal Biotech Announces Orphan Drug Designation Granted to KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
KRYS | $164.04 -3.3% -3.41% 280K
|
Health Technology
|
| O: 0.76%
H: 1.95%
C: -2.11%
kb408 drug biotech granted treatment designation
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
Published: 2023-08-29 (Crawled : 11:00) - globenewswire.com
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: -1.68%
H: 15.81%
C: 6.49%
drug disease kidney treat designation application
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
Published: 2023-07-11 (Crawled : 11:00) - globenewswire.com
SYBX | $1.74 -1.7% -1.72% 70K
|
Health Technology
|
| O: 5.0%
H: 7.6%
C: 0.47%
synb1934 fda granted treatment designation phenylketonuria fast track designation
European Medicines Agency Grants Orphan Drug Designation for MT-401 developed by Marker Therapeutics for the Treatment of AML Patients
Published: 2023-07-10 (Crawled : 11:00) - globenewswire.com
MRKR | $4.24 -1.62% -1.65% 13K
|
Consumer Services
|
| O: -2.53%
H: 30.26%
C: 26.24%
mt-401 drug treatment designation aml grants therapeutics
KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
Published: 2023-07-06 (Crawled : 11:00) - prnewswire.com
KZIA | $0.3522 2.32% 2.27% 270K
|
Health Technology
|
| O: 7.69%
H: 1.59%
C: -15.08%
fda paxalisib treatment designation tumor therapy fast track designation
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
Published: 2023-06-29 (Crawled : 11:00) - globenewswire.com
GNTA | $3.745 24.83% 19.89% 4.4K
|
n/a
|
| O: -3.06%
H: 5.26%
C: 3.51%
drug treatment designation grants
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
Published: 2023-06-27 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
ACIU | $2.43 0.41% 0.41% 370K
|
Health Technology
|
| O: 11.62%
H: 73.3%
C: 53.85%
aci-24 fda disease active alzheimer’s treat designation fast track designation
ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer
Published: 2023-06-26 (Crawled : 11:00) - globenewswire.com
ALXO M | $15.72 -2.24% -2.29% 670K
|
Commercial Services
|
| O: 0.9%
H: 0.0%
C: -5.75%
drug cancer treatment designation
Eagle Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for CAL02, Providing Five-Year Exclusivity Extension
Published: 2023-06-14 (Crawled : 11:00) - globenewswire.com
EGRX | $4.505 2.62% 2.55% 140K
|
Health Technology
|
| O: 7.28%
H: 0.0%
C: -11.43%
cal02 fda disease pharmaceuticals designation extension fast track designation
Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency
Published: 2023-05-25 (Crawled : 11:00) - globenewswire.com
APLT A | $4.74 -1.86% -1.9% 720K
|
Health Technology
|
| O: 2.14%
H: 4.2%
C: -6.29%
at-007 treatment designation ema
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.